Insiders · Profile

Conterno Enrique A

Chief Executive Officer at KYNTRA BIO · SVP&Pres, LillyDiab & LillyUSA at Lilly (Eli). Filing since 2 Apr 2012. CIK 0001476151

Company
Date
Role
Action
Shares
Amount
Of holding
7 Jul 2023
Chief Executive Officer
Sold at will
1,880
$5.26K
0.5%
7 Jun 2023
Chief Executive Officer
Sold at will
8,897
$151.58K
2.3%
10 Apr 2023
Chief Executive Officer
Sold at will
1,869
$36.48K
0.5%
10 Mar 2023
Chief Executive Officer
Sold, plan not stated
31,589
$638.01K
7.6%
8 Mar 2023
Chief Executive Officer
Sold, plan not stated
24,672
$521.96K
6.5%
6 Jan 2023
Chief Executive Officer
Sold, plan not stated
1,538
$30.68K
0.5%
8 Dec 2022
Chief Executive Officer
Sold, plan not stated
2,543
$40.15K
0.8%
11 Jun 2020
Chief Executive Officer
Bought
19,800
$698.60K
248%
10 Jun 2020
Chief Executive Officer
Bought
8,000
$290.28K
opened
15 Feb 2019
SVP&Pres, LillyDiab & LillyUSA
Sold, plan not stated
25,000
$3.03M
15.8%
31 May 2018
SVP&Pres, LillyDiab & LillyUSA
Sold, plan not stated
25,000
$2.13M
16.7%
4 May 2017
SVP&Pres, LillyDiab & LillyUSA
Sold, plan not stated
25,000
$2.07M
18.0%
9 Dec 2015
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
25,000
$2.10M
22.1%
3 Nov 2014
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$330.15K
6.4%
1 Oct 2014
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$324.30K
6.0%
2 Sep 2014
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$318.00K
5.7%
25 Jul 2014
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
10,000
$637.90K
10.2%
15 Aug 2013
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$268.95K
8.0%
15 Jul 2013
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$257.15K
7.4%
17 Jun 2013
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$262.25K
6.9%
15 May 2013
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$280.75K
6.5%
15 Apr 2013
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$285.50K
6.5%
1 Aug 2012
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$220.80K
15.6%
2 Jul 2012
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$215.00K
13.5%
1 Jun 2012
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$203.00K
11.9%
1 May 2012
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$206.60K
10.6%
2 Apr 2012
Sr. VP & Pres., Lilly Diabetes
Sold, plan not stated
5,000
$201.50K
9.6%
27 decisions on file.